+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

World Biopharmaceuticals Market - Opportunities and Forecasts, 2017 - 2023

  • ID: 3773323
  • Report
  • September 2019
  • Region: Global
  • Allied Analytics LLP
1 of 2

Enquire about COVID-19 updates for this product.

Enquire Now
Biopharmaceuticals are drugs produced from genetically modified source, which are mainly proteins and nucleic acids. According to IMS Health Market Prognosis, the total market size of pharmaceutical industry was approximately $962.1 billion in 2012. The market for the biopharmaceuticals drug was $149 billion in 2010. The factors driving the market are, increase in regulatory approvals for biotechnology products. One such product is the recombinant DNA-based products, which has high rates of approval from regulatory authorities. The opportunities of this market are the ageing population and increase in the number of diseases. The challenges of this market are the reimbursement and pricing policy that are the limiting factors in the launch of high priced drugs.

Key player profiled in the report are Pfizer, Inc., Ranbaxy Laboratories Ltd., Roche Holding AG, Abbott Laboratories, Inc., Bayer AG, Biocon Ltd, Eli Lilly and Company, Genentech, Inc., GlaxoSmithKline, PLC. Johnson & Johnson, Inc., LG Life Sciences and Novartis AG

KEY BENEFITS

The report evaluates the key factors that prove to be drivers and restraints for the market
The report discuses the market based on the various segments to forecast growth till 2020.
The report discuses the market factors in various geographic regions and also explores business opportunities
The report analyzes the strategies applied by the profiled key players in the market
Assessment and ranking the factors that favor the market growth and those factors which act as a hindrance for the growth of the market

KEY MARKET SEGMENTSBY THERAPEUTICS

Neurology
Infectious Diseases
Diabetes
Oncology
Cardiovascular
Other Therapeutic Areas

BY PRODUCTS

Monoclonal Antibodies (mAb)
Erythropoietin
Biotech Vaccines
Recombinant Human (RH) Insulin
Granulocyte Colony-Stimulating Factor (G-CSF)
Interferon
Human Growth Hormones (HGH)
Other Biopharmaceuticals

KEY AUDIENCES

Pharmaceutical companies
Research institutes
Health care organizations

Note: Product cover images may vary from those shown
2 of 2

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Adroll
adroll